Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/04/2003US20030225251 Specificity exchangers that redirect antibodies to a pathogen
12/04/2003US20030225250 Intestinal trefoil proteins
12/04/2003US20030225248 186 human secreted proteins
12/04/2003US20030225124 Mixing an ACE inhibitor with an alcohol to form an alcoholic dispersion; mixing a metal compound into said dispersion; and mixing said dispersion and said metal compound; stabilized ACE inhibitor is quinapril sodium or enalapril sodium
12/04/2003US20030225096 Administering a growth hormone secretagogue.
12/04/2003US20030225095 Method of affecting sleep and sleep-related behaviors
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225067 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (CNS) and/or in other parenchymal organs
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003US20030225037 Method for the treatment or prevention of Flaviviridea viral infection using nucleoside analogues
12/04/2003US20030225034 Preventing and treating vaginitis, preterm labor, post-operative pelvis infection, infertility, and sexually transmitted diseases with surfactant lipids, especially surfactant protein A
12/04/2003US20030225027 Used to reduce resistance of cancer cells to treatment with an anticancer drug that generates oxidative stress
12/04/2003US20030225026 Inhibiting receptor-type tyrosine phosphatase epsilon activity or expression in tumor cells
12/04/2003US20030225023 Gene SHINC-2 and diagnostic and therapeutic uses thereof
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030225020 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
12/04/2003US20030225019 Notch1 inhibitors for inducing apoptosis
12/04/2003US20030225018 Modulating angiogenesis in an animal by modulating the expression or activity of syndecan-2.
12/04/2003US20030225015 Treating developmental disorders, aberrant apoptosis, and hyperproliferative disorders such as cancer
12/04/2003US20030225014 Antisense modulation of PLML expression
12/04/2003US20030225013 Oligonucleotide that specifically hybridizes with a nucleic acid encoding phosphoinositide-3-kinase, regulatory subunit 4, p150 and inhibits its expression; treating hyperproliferative and metabolic disorders
12/04/2003US20030225012 Antisense modulation of transcription factor DP-1 expression
12/04/2003US20030225011 Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease
12/04/2003US20030225010 Novel compositions and methods for the regulation of proliferation of stem cells
12/04/2003US20030225009 28 human secreted proteins
12/04/2003US20030225008 Diagnosis of abnormal cellular proliferation by examining or monitoring cells for perturbations in H37 expression; treatment by inserting into H37 protein into a host cell
12/04/2003US20030225000 Parathyroid hormone; stabilizer, especially a polyol stabilizer; buffer to maintain the pH at 3-7; and water
12/04/2003US20030224999 Novel indole peptidomimetics as thrombin receptor antagonists
12/04/2003US20030224998 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/04/2003US20030224997 Synthetic peptide whose amino acid sequence is different from an initial loop of cobra cardiotoxin; also treating HIV-1 infection or autoimmune diseases
12/04/2003US20030224996 Comprising a matrix containing pure natural-sourced mammalian osteogenic protein
12/04/2003US20030224995 Treatment of burns
12/04/2003US20030224994 Storage stable liquid sealer protein complex
12/04/2003US20030224993 Compositions that inhibit proliferation of cancer cells
12/04/2003US20030224991 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
12/04/2003US20030224990 IGF-binding protein-derived peptide or small molecule
12/04/2003US20030224989 Compositions and methods for treatment of osteoarthritis
12/04/2003US20030224988 Methods of modulating beta cell function
12/04/2003US20030224987 Binding to formyl peptide receptor or formyl peptide receptor-like 1
12/04/2003US20030224986 Method of treating apoptosis and compositions thereof
12/04/2003US20030224985 Enhanced resistance to TS-inhibiting drugs like 5-fluorouracil or 5-fluoro-2-deoxyuridinemonophosphate.
12/04/2003US20030224984 Treating trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.
12/04/2003US20030224983 Stimulation of beta cell proliferation
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224981 Administering a protein comprising at least one binding domain for a laminin and at least one binding domain for alpha-dystroglycan or a nucleic acid encoding the protein
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224979 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
12/04/2003US20030224978 Compounds and methods for modulating apoptosis
12/04/2003US20030224977 Inhibitors of the HCV NS3 protease.
12/04/2003US20030224976 Compositions, methods and kits relating to behab and primary CNS tumors
12/04/2003US20030224975 Glycopeptide antibacterial compounds, compositions containing same and methods of using same
12/04/2003US20030224973 Minimising body gain in insulin treatment
12/04/2003US20030224969 Specific nucleotides or proteins encoded thereby are used in assays to identify inhibitors of human analogs of murine hematopoetic-specific, cytokine-inducible deubiquinating proteases
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224967 Use of mass spectrometry to analyze peptides and amino acids in the field of proteomics
12/04/2003US20030224516 Comprises oligonucleotides for controlling expression of prospero- related homeobox 1 (PROX-1) and treatment of metabolic and vision disorders
12/04/2003US20030224515 Comprises oligonucleotides for controlling expression of regulatory protein and treatment of metabolic, diabetic, atherosclerotic, cardiovascular and hyperlipidemic
12/04/2003US20030224514 Antisense modulation of PPAR-delta expression
12/04/2003US20030224513 Antisense modulation of Notch1 expression
12/04/2003US20030224512 Antisense modulation of beta-site APP-cleaving enzyme expression
12/04/2003US20030224511 Oligonucleotide for preventing cysteine protease expression (CAPTHESIN Z) and treatment of viral, infectious and tumor diseases
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224486 Polynucleotides and polypeptides associated with the NF-kB pathway
12/04/2003US20030224476 Enhancing transglutaminase reactivity for use in food processing and flavor improvement
12/04/2003US20030224475 Lipodepsipeptide antibiotics and methods of preparation
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224460 Novel compositions and methods for lymphoma and leukemia
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224451 Novel protein related to melanoma-inhibiting protein and uses thereof
12/04/2003US20030224450 Comprises nucleotide sequences coding transient receptor potential channel (TRP) for use in diagnosis and treatment of osteoporosis, nervous system, kidney and cancer disorders
12/04/2003US20030224430 Regulation of human eosinophil serine protease 1-like enzyme
12/04/2003US20030224429 DNA sequence encoding a human imidazoline receptor and method for cloning the same
12/04/2003US20030224417 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224402 Progression suppressed gene 13 (PSGen 13) and uses thereof
12/04/2003US20030224400 Novel human G-protein coupled receptor, HGPRBMY11, and variants thereof
12/04/2003US20030224396 Regulation of human aminotransferase-like enzyme
12/04/2003US20030224379 Novel nucleic acids and polypeptides
12/04/2003US20030224378 Novel human protein kinases and protein kinase-like enzymes
12/04/2003US20030224376 Novel human transferase family members and uses thereof
12/04/2003US20030224367 Novel polypeptides and nucleic acids encoding same
12/04/2003US20030224362 Diagnosing alcoholism using presence of mutation in neuropeptide y gene; drug abuse; restriction fragment length polymorphisms; immunoassay
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224355 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (alpha), HNF-1beta and HNF-4alpha
12/04/2003US20030224353 Uncharged oligomers having a targeting base sequence that is substantially complementary to a viral target sequence which spans the AUG start site of the first open reading frame of the viral genome
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224343 Kappa-PVIIA-related conotoxins as organ protectants
12/04/2003US20030224059 Drug microparticles
12/04/2003US20030224056 Hemostatic composition
12/04/2003US20030224052 Water soluble proteins (especially hair) and covalent interprotein crosslinks other than disulfide crosslinks.
12/04/2003US20030224040 Genomic screen for epigenetically silenced genes associated with cancer
12/04/2003US20030224020 Homogenizing an emulsion comprising the toxin, lactose in phosphatidylcholine liposome for drug delivery
12/04/2003US20030224019 Administering a therapeutically effective amount of Botulinum toxin type B to a patient suffering from nerve entrapment syndrome ( carpal tunnel syndrome, piriformis syndrome, cubital tunnel syndrome, and radial tunnel syndrome)
12/04/2003US20030224016 Transport peptides such as C-terminal Erns peptide and analogues thereof
12/04/2003US20030224015 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
12/04/2003US20030224014 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
1 ... 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 ... 3163